Aug 10, 2018 Patisiran Wins Two Firsts With FDA Approval Patisiran Wins Two Firsts With FDA ApprovalIn the phase III APOLLO trial, patisiran slowed peripheral neuropathy progression in patients with hATTR amyloidosis, improving neurological ... read morePublished on 2018-08-10